Lv6
1698 积分 2025-05-09 加入
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
5天前
已完结
Economic evaluation of camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma in the United States and China
8天前
已完结
A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
8天前
已完结
A Randomized Trial of Etanercept as Monotherapy for Psoriasis
10天前
已完结
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction
10天前
已完结
Comparison of Biologics and Oral Treatments for Plaque Psoriasis
10天前
已完结
Anti-PD-L1 envafolimab combined with anti-VEGF suvemcitug in pretreated solid tumors and hepatocellular carcinoma: an open-label phase II study with safety run-in stage
12天前
已完结
Efficacy and safety of PD‐L1 blockade envafolimab as neoadjuvant treatment in mismatch repair‐deficient, locally advanced colorectal cancer: An open‐label, single‐arm study
12天前
已完结
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors
12天前
已完结
Cost-effectiveness analysis of trilaciclib for reducing the incidence of chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer in China
12天前
已完结
皖公网安备34019202002308
